Collaborate Disseminate
If you’ve ever caught the flu, you’ve more than likely been infected with the Influenza A virus (IAV). Compared to the Influenza B virus, infection with the A type often produces more severe symptoms. But, while many of us have experienced the fever an… Continue reading New flu drug aims to keep you in a ‘Goldilocks zone’ of lung inflammation
If you’ve ever caught the flu, you’ve more than likely been infected with the Influenza A virus (IAV). Compared to the Influenza B virus, infection with the A type often produces more severe symptoms. But, while many of us have experienced the fever an… Continue reading New flu drug aims to keep you in a ‘Goldilocks zone’ of lung inflammation
As common as asthma is, exactly how it starts remains murky. Scientists have now identified a new root cause, and importantly a new angle for treating the disease that can prevent the main symptoms.
Tags: King’s College London, Asthma, Cells, Disease, Inflammatory
Continue reading New asthma cause identified – and a new angle for treatment
Giving an immunotherapy drug as soon as possible after diagnosis with Crohn’s disease significantly reduces complications, including the need for surgery by a factor of 10, a clinical study has found. Compared to conventional treatment, which favors de… Continue reading 79% of Crohn’s disease patients in remission after early intervention
Perhaps one of the most persistent debates around COVID has been the reason behind the disease’s neurological symptoms. Ever since SARS-CoV-2 emerged in late 2019 the virus has been known for its novel effects on the brain: Extreme fatigue, cognitive a… Continue reading Inflammation or infection: The debate over COVID’s effect on the brain
Researchers have developed drug-loaded nanoparticles that selectively target the cells responsible for causing damaging inflammation following a spinal cord injury. Given to mice soon after an injury, the novel therapy reduced inflammation and improved… Continue reading Drug-loaded nanoparticles may prevent paralysis from spinal cord injury
A drug currently used as a second- or third-line treatment for those with rheumatoid arthritis has shown huge promise as a preventative, stopping the onset of the debilitating disease in 92.8% of at-risk participants after 12 months.
Tags: King’s College London, Arthritis, Rheumatoid arthritis, Pain, Joints, Inflammatory, Aging, Age-Related
Continue reading Existing jab offers “ray of hope” for preventing rheumatoid arthritis
In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential ‘superpower’ in the fight against Alzheimer’s and Parkinson’s diseases.
Tags: University of Toronto, Ozempic, GLP1, Alzheimer’s Disease, Parkinson’s Disease, Inflammatory, Brain, Dementia
Continue reading GLP-1 weight-loss drugs may pivot to treat Alzheimer’s and Parkinson’s
By fitting microparticle ‘backpacks’ to important inflammatory cells called macrophages, researchers significantly reduced lesion size and inflammation caused by traumatic brain injury. Working with biology rather than against it, this novel approach h… Continue reading Cells wearing ‘backpacks’ shrink traumatic brain injury lesions by 56%
Researchers have developed a novel non-steroidal anti-inflammatory from the active ingredient in a medicinal plant used throughout Southeast Asia. The novel compound doesn’t suppress the innate immune system like currently used corticosteroids do, open… Continue reading Plant non-steroidal anti-inflammatory leaves immune system intact